As of 1:11pm ET
| +0.125 / +3.71%|
The 2 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a -57.08% decrease from the last price of 3.50.
The current consensus among 4 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.